Difference between revisions of "Part:BBa K4905021"
VeerleJegers (Talk | contribs) |
|||
Line 3: | Line 3: | ||
<partinfo>BBa_K4905021 short</partinfo> | <partinfo>BBa_K4905021 short</partinfo> | ||
− | IL-10 | + | <html> |
+ | <body> | ||
+ | <p> | ||
+ | This composite part is made with the basic parts Outer membrane protein F (OmpF) (<a href="https://parts.igem.org/Part:BBa_K2302005">BBa_K2302005</a>), Interleukin 10 (IL-10) (<a href="https://parts.igem.org/Part:BBa_K554004">BBa_K554004</a>), and Polyhistadine-tag (His-tag) (<a href="https://parts.igem.org/Part:BBa_K3630006">BBa_K3630006</a>). This forms the construct OmpF-IL10-His. The TU Eindhoven 2023 team used it as a therapeutic against Inflammatory Bowel disease (IBD). | ||
+ | </p> | ||
+ | <p> | ||
+ | IL-10 is important for regulating inflammation<sup>[1]</sup>. It is immunosuppressive with effect on macrophages and dendritic cells. Animal studies show that mice with IL-10 deficiency develop severe colitis, but not when recombinant IL-10 is systemically applied. With the anti-inflammatory effect of IL-10, it can be used to treat IBD and other autoimmune disorders. However, an oral intake or injection with only IL-10 induces side effects. The options are also limited because of the acid sensitivity of IL-10. Genetically modified organisms are an alternative for delivering IL-10 at the right place of the inflammation. In our case with <i>E.coli</i> BL21 cells as carrier. | ||
+ | </p> | ||
+ | <p> | ||
+ | For the expression of IL-10 by <i>E.coli</i>, OmpF is added to the construct. This is a major outer membrane porin that can secrete gene products from <i>E.coli</i>. It causes the construct to form an artificial transporter such that IL-10 can cross the cytoplasmic membrane. On the other side of IL-10, we added a His-tag. This is used for affinity purification of the construct. | ||
+ | </p> | ||
+ | </body> | ||
+ | </html> | ||
− | + | <span class='h3bb'><h1>Sequence and Features</h1></span> | |
− | + | ||
− | + | ||
− | + | ||
− | <span class='h3bb'>Sequence and Features</span> | + | |
<partinfo>BBa_K4905021 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4905021 SequenceAndFeatures</partinfo> | ||
− | + | <html> | |
− | < | + | <body> |
− | + | <h1>References</h1> | |
− | < | + | <p> |
− | < | + | [1] Pöhlmann, C., Brandt, M., Mottok, D. S., Zschüttig, A., Campbell, J. W., Blattner, F. R., Frisch, D., & Gunzer, F. (2012). Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide. Journal of Molecular Microbiology and Biotechnology, 22(1), 1–9. https://doi.org/10.1159/000336043 |
+ | </p> | ||
+ | </body> | ||
+ | </html> |
Latest revision as of 08:23, 3 October 2023
Ompf-IL10-His
This composite part is made with the basic parts Outer membrane protein F (OmpF) (BBa_K2302005), Interleukin 10 (IL-10) (BBa_K554004), and Polyhistadine-tag (His-tag) (BBa_K3630006). This forms the construct OmpF-IL10-His. The TU Eindhoven 2023 team used it as a therapeutic against Inflammatory Bowel disease (IBD).
IL-10 is important for regulating inflammation[1]. It is immunosuppressive with effect on macrophages and dendritic cells. Animal studies show that mice with IL-10 deficiency develop severe colitis, but not when recombinant IL-10 is systemically applied. With the anti-inflammatory effect of IL-10, it can be used to treat IBD and other autoimmune disorders. However, an oral intake or injection with only IL-10 induces side effects. The options are also limited because of the acid sensitivity of IL-10. Genetically modified organisms are an alternative for delivering IL-10 at the right place of the inflammation. In our case with E.coli BL21 cells as carrier.
For the expression of IL-10 by E.coli, OmpF is added to the construct. This is a major outer membrane porin that can secrete gene products from E.coli. It causes the construct to form an artificial transporter such that IL-10 can cross the cytoplasmic membrane. On the other side of IL-10, we added a His-tag. This is used for affinity purification of the construct.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
[1] Pöhlmann, C., Brandt, M., Mottok, D. S., Zschüttig, A., Campbell, J. W., Blattner, F. R., Frisch, D., & Gunzer, F. (2012). Periplasmic Delivery of Biologically Active Human Interleukin-10 in Escherichia coli via a Sec-Dependent Signal Peptide. Journal of Molecular Microbiology and Biotechnology, 22(1), 1–9. https://doi.org/10.1159/000336043